Stockholm - Delayed Quote
SEK
Egetis Therapeutics AB (publ) (EGTX.ST)
10.06
-0.28
(-2.71%)
At close: October 30 at 12:59:37 PM GMT+1
Loading chart for EGTX.ST
- Previous Close
10.34 - Open
10.34 - Bid 10.02 x --
- Ask 10.08 x --
- Day's Range
10.00 - 10.48 - 52 Week Range
3.62 - 10.82 - Volume
1,029,096 - Avg. Volume
2,146,072 - Market Cap (intraday)
4.678B - Beta (5Y Monthly) 0.78
- PE Ratio (TTM)
-- - EPS (TTM)
-1.00 - Earnings Date Nov 6, 2026
- Forward Dividend & Yield -- (0.00%)
- Ex-Dividend Date --
- 1y Target Est
18.33
Recent News
View MorePerformance Overview
Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index (^OMX) .
YTD Return
EGTX.ST
88.39%
OMX Stockholm 30 Index (^OMX)
13.47%
1-Year Return
EGTX.ST
57.19%
OMX Stockholm 30 Index (^OMX)
17.56%
3-Year Return
EGTX.ST
113.82%
OMX Stockholm 30 Index (^OMX)
59.03%
5-Year Return
EGTX.ST
95.79%
OMX Stockholm 30 Index (^OMX)
42.80%
Earnings Trends
View MoreAnalyst Insights
View MoreStatistics
View MoreValuation Measures
-
Market Cap
-
Enterprise Value
-
Trailing P/E
-
Forward P/E
-
PEG Ratio (current)
-
Price/Sales (ttm)
-
Price/Book (mrq)
-
Enterprise Value/Revenue
-
Enterprise Value/EBITDA
Financial Highlights
Profitability and Income Statement
-
Profit Margin
0.00%
-
Return on Assets (ttm)
-34.38%
-
Return on Equity (ttm)
-96.92%
-
Revenue (ttm)
66M
-
Net Income Avi to Common (ttm)
-405.4M
-
Diluted EPS (ttm)
-1.00
Balance Sheet and Cash Flow
-
Total Cash (mrq)
378.4M
-
Total Debt/Equity (mrq)
14.29%
-
Levered Free Cash Flow (ttm)
-148.8M
